UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
butyrylcholinesterase - metabolism (1996) 1996
science & technology (1727) 1727
humans (1682) 1682
life sciences & biomedicine (1641) 1641
animals (1528) 1528
acetylcholinesterase - metabolism (1353) 1353
butyrylcholinesterase (1008) 1008
cholinesterase inhibitors - pharmacology (915) 915
male (783) 783
acetylcholinesterase (745) 745
biological and medical sciences (719) 719
cholinesterase inhibitors - chemistry (605) 605
female (574) 574
pharmacology & pharmacy (563) 563
biochemistry & molecular biology (498) 498
butyrylcholinesterase - blood (492) 492
alzheimer's disease (485) 485
medical sciences (480) 480
rats (476) 476
butyrylcholinesterase - chemistry (437) 437
kinetics (436) 436
structure-activity relationship (433) 433
cholinesterase inhibitors - chemical synthesis (388) 388
cholinesterases - metabolism (376) 376
enzymes (366) 366
mice (345) 345
alzheimer disease - drug therapy (334) 334
butyrylcholinesterase - genetics (332) 332
chemistry (322) 322
toxicology (313) 313
molecular structure (310) 310
dose-response relationship, drug (306) 306
physical sciences (302) 302
analysis (296) 296
acetylcholinesterase - chemistry (271) 271
models, molecular (271) 271
fundamental and applied biological sciences. psychology (269) 269
cholinesterase (264) 264
neurosciences (250) 250
neurosciences & neurology (248) 248
chemistry, medicinal (244) 244
pharmacology. drug treatments (232) 232
binding sites (226) 226
brain - enzymology (225) 225
adult (223) 223
middle aged (217) 217
molecular docking simulation (206) 206
hydrolysis (202) 202
aged (199) 199
horses (186) 186
alzheimer’s disease (181) 181
alzheimer disease - enzymology (168) 168
acetylcholinesterase - blood (167) 167
cholinesterase inhibitors - metabolism (162) 162
drug design (158) 158
cholinesterase inhibitors (155) 155
rats, wistar (141) 141
cholinesterase inhibitors - therapeutic use (137) 137
neuropharmacology (129) 129
protein binding (129) 129
alzheimer disease - metabolism (127) 127
time factors (125) 125
acetylcholine (124) 124
brain - drug effects (122) 122
cholinesterases (122) 122
antioxidants - pharmacology (121) 121
chemistry, multidisciplinary (121) 121
cholinesterase inhibitors - toxicity (121) 121
enzyme inhibitors (120) 120
antioxidants (117) 117
in vitro techniques (113) 113
substrate specificity (113) 113
inhibitory concentration 50 (112) 112
amyloid beta-peptides - metabolism (110) 110
hydrolases (110) 110
electrophorus (109) 109
acetylcholinesterase - genetics (106) 106
butyrylcholinesterase - drug effects (104) 104
research (104) 104
neurology (101) 101
cholinesterases - blood (99) 99
physiological aspects (99) 99
brain (93) 93
acetylcholine - metabolism (91) 91
butyrylcholinesterase - deficiency (91) 91
psychology. psychoanalysis. psychiatry (91) 91
plant extracts - pharmacology (90) 90
brain - metabolism (89) 89
inhibition (89) 89
neuroprotective agents - pharmacology (89) 89
analytical, structural and metabolic biochemistry (87) 87
biophysics (87) 87
catalytic domain (87) 87
life sciences (87) 87
rats, sprague-dawley (87) 87
antioxidants - chemistry (86) 86
cholinesterase inhibitors - isolation & purification (84) 84
recombinant proteins - metabolism (83) 83
catalysis (82) 82
erythrocytes - enzymology (82) 82
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2868) 2868
Russian (69) 69
German (33) 33
French (30) 30
Japanese (21) 21
Portuguese (12) 12
Italian (9) 9
Chinese (8) 8
Czech (6) 6
Spanish (4) 4
Croatian (2) 2
Polish (2) 2
Danish (1) 1
Dutch (1) 1
Hebrew (1) 1
Korean (1) 1
Romanian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Current protein & peptide science, ISSN 1389-2037, 01/2020, Volume 21, Issue 1, pp. 99 - 109
Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Recombinant Proteins - therapeutic use | Cocaine - metabolism | Butyrylcholinesterase - genetics | Obesity - drug therapy | Humans | Substrate Specificity | Acetylcholine - metabolism | Parkinson Disease - drug therapy | Cocaine-Related Disorders - genetics | Obesity - genetics | Synaptic Transmission | Acetylcholinesterase - genetics | Alzheimer Disease - pathology | Brain - metabolism | Cocaine-Related Disorders - metabolism | Amyloid beta-Peptides - genetics | Butyrylcholinesterase - metabolism | Amyloid beta-Peptides - metabolism | Parkinson Disease - metabolism | Cocaine - antagonists & inhibitors | Molecular Targeted Therapy - methods | Recombinant Proteins - metabolism | Parkinson Disease - pathology | Ghrelin - genetics | Neurotransmitter Agents - metabolism | Alzheimer Disease - drug therapy | Cocaine-Related Disorders - pathology | Recombinant Proteins - genetics | Parkinson Disease - genetics | Butyrylcholinesterase - therapeutic use | Obesity - metabolism | Obesity - pathology | Brain - drug effects | Ghrelin - antagonists & inhibitors | Ghrelin - metabolism | Amyloid beta-Peptides - antagonists & inhibitors | Alzheimer Disease - metabolism | Cocaine-Related Disorders - drug therapy | Alzheimer Disease - genetics | Acetylcholinesterase - metabolism | Drug abuse | Brain | Serine | Disorders | Esters | Acetylcholinesterase | Hunger | Ghrelin | Alzheimer's disease | Enzymes | Narcotics | Neurodegenerative diseases | Hydrolase | Pharmacology | Serine hydrolase | Gene expression | Substrates | Mutants | Neurological diseases | Cholinergics | Neurotransmitters | Addiction | Cocaine | Acetylcholine | Gene therapy | Neurotransmission
Journal Article
Journal Article
Journal Article
Journal Article
Food and chemical toxicology, ISSN 0278-6915, 09/2013, Volume 59, pp. 96 - 103
Enzyme inhibition | Anethum graveolens | Oil | Dill | Phenolic acid | Antioxidant activity | Food Science & Technology | Toxicology | Life Sciences & Biomedicine | Science & Technology | Biological and medical sciences | Medical sciences | Oils, Volatile - chemistry | Plant Extracts - pharmacology | Solvents - chemistry | Anethum graveolens - chemistry | Antioxidants - metabolism | Oils, Volatile - pharmacology | Iron Chelating Agents - metabolism | Butyrylcholinesterase - chemistry | Cholinesterase Inhibitors - metabolism | Butyrylcholinesterase - metabolism | Cholinesterase Inhibitors - isolation & purification | Fish Proteins - antagonists & inhibitors | Enzyme Inhibitors - metabolism | Fruit - chemistry | Enzyme Inhibitors - pharmacology | Fish Proteins - metabolism | Cholinesterase Inhibitors - analysis | Electrophorus | Enzyme Inhibitors - analysis | Food, Organic - analysis | Plant Extracts - isolation & purification | Acetylcholinesterase - chemistry | Enzyme Inhibitors - isolation & purification | Iron Chelating Agents - analysis | Iron Chelating Agents - isolation & purification | Fruit - growth & development | Cholinesterase Inhibitors - pharmacology | Antioxidants - isolation & purification | Monoterpenes - metabolism | Monoterpenes - analysis | Acetylcholinesterase - metabolism | Plant Extracts - chemistry | Anethum graveolens - metabolism | Depsides - analysis | Fungal Proteins - antagonists & inhibitors | Monophenol Monooxygenase - antagonists & inhibitors | Monophenol Monooxygenase - metabolism | Cinnamates - metabolism | Antioxidants - analysis | Fruit - metabolism | Depsides - metabolism | Nitric Oxide - antagonists & inhibitors | Antioxidants - pharmacology | Oils, Volatile - isolation & purification | Drug Discovery | Animals | Iron Chelating Agents - pharmacology | Horses | Cinnamates - analysis | Anethum graveolens - growth & development | Fungal Proteins - metabolism | Antioxidants | Monounsaturated fatty acids | Analysis | Index Medicus
Journal Article
Journal of medicinal chemistry, ISSN 0022-2623, 05/2009, Volume 52, Issue 9, pp. 2724 - 2732
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer | Psychology. Psychoanalysis. Psychiatry | Psychopharmacology | Pharmacology. Drug treatments | Biological and medical sciences | Neuroprotective agent | Medical sciences | Neuropharmacology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Calcium - metabolism | Humans | Calcium Channel Blockers - therapeutic use | Cholinesterase Inhibitors - chemistry | Cytosol - drug effects | Dihydropyridines - metabolism | Alzheimer Disease - pathology | Cholinesterase Inhibitors - metabolism | Butyrylcholinesterase - metabolism | Amyloid beta-Peptides - metabolism | Cell Death - drug effects | Calcium Channel Blockers - metabolism | Tacrine - analogs & derivatives | Catalytic Domain | Peptide Fragments - metabolism | Permeability - drug effects | Dihydropyridines - chemistry | Alzheimer Disease - drug therapy | Models, Molecular | Alzheimer Disease - enzymology | Calcium Channel Blockers - pharmacology | Blood-Brain Barrier - drug effects | Blood-Brain Barrier - metabolism | Hydrogen Peroxide - metabolism | Dihydropyridines - therapeutic use | Cholinesterase Inhibitors - pharmacology | Alzheimer Disease - metabolism | Calcium Channel Blockers - chemistry | Cell Line, Tumor | Dihydropyridines - pharmacology | Cytosol - metabolism | Ligands | Kinetics | Cholinesterase Inhibitors - therapeutic use | Acetylcholinesterase - metabolism | Index Medicus
Journal Article
Archives of physiology and biochemistry, ISSN 1381-3455, 05/2017, Volume 123, Issue 3, pp. 165 - 174
potassium bromate | genes expression | fatty acids | vanillin | oxidative stress | Cerebrum | Biochemistry & Molecular Biology | Endocrinology & Metabolism | Physiology | Biophysics | Life Sciences & Biomedicine | Science & Technology | Tumor Necrosis Factor-alpha - metabolism | Sodium-Potassium-Exchanging ATPase - genetics | Superoxide Dismutase - genetics | Butyrylcholinesterase - genetics | Neurotoxicity Syndromes - genetics | Ca(2+) Mg(2+)-ATPase - metabolism | Tumor Necrosis Factor-alpha - genetics | Ca(2+) Mg(2+)-ATPase - genetics | Interleukin-1beta - genetics | Depression - genetics | Protein Carbonylation - drug effects | Neurotoxicity Syndromes - drug therapy | Depression - metabolism | Neuroprotective Agents - pharmacology | Butyrylcholinesterase - metabolism | Cyclooxygenase 2 - genetics | Interleukin-1beta - metabolism | Bromates - toxicity | Depression - chemically induced | Lipid Peroxidation - drug effects | Behavior, Animal - drug effects | Cerebrum - metabolism | Cerebrum - physiopathology | Fatty Acids - metabolism | Interleukin-6 - metabolism | Superoxide Dismutase - metabolism | Cerebrum - drug effects | Glutathione Peroxidase - metabolism | Interleukin-6 - genetics | Benzaldehydes - pharmacology | Antioxidants - pharmacology | Glutathione Peroxidase - genetics | Gene Expression Regulation - drug effects | Sodium-Potassium-Exchanging ATPase - metabolism | Animals | Depression - prevention & control | Cyclooxygenase 2 - metabolism | Neurotoxicity Syndromes - physiopathology | Neurotoxicity Syndromes - metabolism | Mice | Oxidative Stress - drug effects | Index Medicus
Journal Article
Biological trace element research, ISSN 0163-4984, 9/2013, Volume 154, Issue 3, pp. 387 - 395
Journal Article